There is an exploding interest in the development of complex drug composed of hyperlipidemia treatment Rosuvastatin and Ezetimibe

There is an exploding interest in the development of complex drug composed of hyperlipidemia treatment Rosuvastatin and Ezetimibe, with whopping 18 companies involved in developing.

The complex drug with combination of rosuvastatin and ezetimibe makes one’s first appearance in domestic. In particular, many domestic pharmaceutical companies are concentrating power in developing a complex drug c...